Patients taking GLP-1 drugs had a lower rate of opioid overdose and alcohol intoxication than those not taking the drugs, a study published Oct. 16 in Addiction found.
The Latest
Patient preferences could be shifting back toward in-person care for behavioral health, according to LifeStance Health's chief medical officer.
Scott Moran, MD, the former CEO of Clifton T. Perkins Hospital Center in Maryland, was terminated following allegations of misconduct, mismanagement and systemic safety failures at the facility, according to an investigation by The Washington Post investigation.
One in 4 adults believe they have undiagnosed ADHD, according to a survey from The Ohio State University Wexner Medical Center and College of Medicine.
The Drug Enforcement Administration is set to extend rules that allow controlled substances to be prescribed through telehealth, Politico reported Oct. 15.
Acadia Healthcare has acquired three opioid treatment centers in South Carolina.
Overdose deaths among teenagers declined slightly from 2022 to 2023, a shift that could mark the start of a decline in adolescent overdose deaths, according to an analysis from KFF.
Three teenagers were arrested and taken into custody for allegedly inciting a riot at Riverview Behavioral Hospital in Texarkana, Ark.
An Illinois judge has reduced the punitive damages an indirect subsidiary of King of Prussia, Pennsylvania-based Universal Health Services must pay in a negligence case, according to an Oct. 11 regulatory filing.
California is reimagining behavioral health care with a new set of programs that push patients into different systems based on the type and severity of their condition, the California Health Care Foundation reported Oct. 14.
